Home » Our research » Not just small adults: developmental neuroimmune programming determines recovery from leukaemia therapy-induced neuropathy

Not just small adults: developmental neuroimmune programming determines recovery from leukaemia therapy-induced neuropathy

Challenge

Dr Hana Starobova
Dr Hana Starobova

Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most common and debilitating complications of leukemia treatment, particularly in children receiving vincristine for acute lymphoblastic leukaemia (ALL). CIPN causes chronic pain, numbness, muscle weakness, reduced mobility, and long-term disability that can persist for years or decades after treatment has been completed. Despite its significant impact on patients’ quality of life and treatment, there are currently no therapies that directly address the underlying nerve damage.

Focus

Dr Hana Starobova ‘s research investigates how age-related differences in the body’s inflammatory responses influence recovery from vincristine-induced neuropathy. Using clinically relevant models of vincristine-induced neuropathy and immune cells from children and adults with blood cancer, Dr Starobova’s team will explore whether targeting specific inflammatory pathways can improve nerve recovery and whether these responses differ between children and adults. 

Impact

This research directly addresses a major survivorship issue in childhood blood cancers and will provide critical preliminary data for age-specific approaches to protecting nerves from chemotherapy-related damage. In the longer term, this could help reduce lasting side effects, improve quality of life for people affected by blood cancer, and support the delivery of optimal chemotherapy treatment.

Researcher

Dr Hana Starobova is an NHMRC Investigator Fellow at The University of Queensland’s Institute for Molecular Bioscience. With a background in pharmacy and neuroscience, she investigates how immune responses contribute to chemotherapy-induced nerve damage and pain, aiming to improve recovery and long-term quality of life for children and adults affected by cancer.


Patient
Researcher
Leukaemia
Treatment

Research Hub

Related research…